BC
AXSM icon

Burney Company’s Axsome Therapeutics AXSM Stock Holding History

Burney Company’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-9,636
Closed -$1.63M – 612
2026
Q1 		$1.63M Buy
+9,636
New +$1.66M 0.05% 249
2020
Q1 		– Sell
-2,220
Closed -$229K – 431
2019
Q4 		$229K Buy
+2,220
New +$89.7K 0.01% 436

Other funds holding AXSM

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
BWP
Baldwin Wealth Partners Marion, Massachusetts $1.53B AUM 28.5% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
PCM
Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
TAM
Tealwood Asset Management Minneapolis, Minnesota $261M AUM 52.68% 1-Year Est. Return
CA
Cannon Advisors Charlotte, North Carolina $164M AUM 30.34% 1-Year Est. Return
MCP
Mirador Capital Partners Pleasanton, California $817M AUM 42.46% 1-Year Est. Return

Burney Company's AXSM Position: Q2 2026 in Review

Burney Company sold out of Axsome Therapeutics (AXSM) in Q2 2026, closing a stake of 9,636 shares — an estimated $1.63M sold.

Burney Company first reported a position in AXSM in Q4 2019 and held it in 2 quarters. The position peaked at $1.63M in Q1 2026. 38 funds tracked by Wall St. Rank hold AXSM as of Q2 2026.

  • Burney Company reported no remaining Axsome Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Burney Company sold 9,636 Axsome Therapeutics shares in Q2 2026, an estimated $1.63M.
  • Burney Company first reported a position in Axsome Therapeutics in Q4 2019 and held it in 2 quarters.
  • Burney Company's Axsome Therapeutics position peaked at $1.63M in Q1 2026.
  • 38 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q2 2026.

Based on Burney Company's 13F filing for Q2 2026, filed 15 Jul 2026.